Viewing StudyNCT00515086



Ignite Creation Date: 2024-05-05 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00515086
Status: TERMINATED
Last Update Posted: 2011-09-22
First Post: 2007-08-10

Brief Title: Study of Everolimus RAD001 in Patients With Recurrent Glioblastoma Multiforme GBM
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Glioblastoma Multiforme
Keywords:
Name View
Glioblastoma Multiforme GBM RAD001 RAD View